Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
Ildiko Lingvay, A. Michael Lincoff, Helen M. Colhoun, Rafael Bravo et al.
Citations
35 citations
Journal
The Lancet
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
45.32
article
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
Ildiko Lingvay, A. Michael Lincoff, Helen M. Colhoun, Rafael Bravo, Chau‐Chung Wu, Signe Stensen, Ferruccio Santini, Benjamin M. Scirica, Jorge Plutzky, Silvio Buscemi, Ole Kleist Jeppesen, Issei Komuro, Peter Weeke, G Kees Hovingh, Steven E. Kahn, Jøran Hjelmesæth, Miguel Urina‐Triana, Donna H. Ryan, Scott S. Emerson, John Deanfield, Robert F. Kushner
article en
35 citations
Abstract
No abstract available for this paper.
Publication Tag
The LancetVol. 406(10516)
Institutions
Pennington Biomedical Research Center (US), University of Pisa (IT), Northwestern University (US), Brigham and Women's Hospital (US), Harvard University (US), Novo Nordisk (Denmark) (DK), University of Washington (US), Sykehuset i Vestfold (NO), Cleveland Clinic Lerner College of Medicine (US), VA Puget Sound Health Care System (US), Southwestern Medical Center (US), National Taiwan University Hospital (TW), Universidad Simón Bolívar (CO), The London College (GB), Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT), Institute of Genetics and Cancer (GB), Thrombolysis in Myocardial Infarction Study Group (US), University College London (GB), International University of Health and Welfare (JP), The University of Texas Southwestern Medical Center (US), University of Palermo (IT), University of Edinburgh (GB)
Funders
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Brigham and Women's Hospital, CSL Behring, Regeneron Pharmaceuticals, TG Therapeutics, Sarnoff Cardiovascular Research Foundation, Novavax, MannKind Corporation, Kowa Company, Mylan, BeiGene, Boehringer Ingelheim Japan, Amryt Pharma, Toa Eiyo, Moderna, Insmed, Diabetes UK, European Commission, Novo Nordisk, Shionogi, Servier, Ono Pharmaceutical, H. Lundbeck A/S, Ipsen, Idorsia Pharmaceuticals, Esperion Therapeutics, Medical Research Council, Daiichi Sankyo Europe